Skip to main content

Table 1 The half maximal inhibitory dose (IC50), half maximal cytotoxic concentration (CC50), and half maximal cytomorbidity concentration (MC50) for each compound

From: Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives

Drug name

IC50 (µg/ml)

IC50 (uM)

CC50 (µg/ml)

CC50 (µM)

MC50 (µg/ml)

MC50 (µM)

Hydroxychloroquine

19

43.78

NA

NA

39.8

91.72

Nitazoxanide

NA

NA

1.36

4.43

2.82

9.18

Oleuropein

NA

NA

NA

NA

24

44.40

Gamma-mangostin

NA

NA

3.31

8.35

1.47

3.70

DidemninB

0.04

0.36

NA

NA

0.013

0.12

Cycloheximide

0.0002

0.0007

0.0022

0.0078

0.000054

0.00019

Remdesivir

0.83

1.38

96.2

159.64

67.3

111.68

Ribavirin

NA

NA

NA

NA

26.1

106.88

CyclosporineA

NA

NA

57.3

47.65

13.6

11.31

Linoleic acid

17.7

63.9

40.2

144.9

18.2

65.6